Colony-stimulating factors (CSF)' are a family of glycoproteins that support the clonal proliferation and differentiation of hematopoietic progenitor cells in vitro (1) (2) (3) . As pluripotent stem cells generate committed progenitor cells of a specific lineage, the number of soluble factors capable of inducing proliferation and/or differentiation of these cells becomes more restricted . This observation has allowed CSFs to be broadly classified into either multilineage or lineagespecific growth factors . Lineage-specific CSFs are those acting on cells capable of forming only one differentiated cell type (4) . Granulocyte-CSF (G-CSF), macrophage-CSF (M-CSF), or erythropoietin (EPO) are lineage-specific CSFs that stimulate the proliferation and differentiation of committed progenitor cells into granulocytes, macrophages, or erythrocytes, respectively (5-7). Multilineage CSFs are those stimulating primitive multipotent cells that generate more than one fully differentiated cell type. Granulocyte/macrophage-CSF (G/M-CSF) and IL-3 (multi-CSF) are two distinct multilineage CSFs that support the proliferation of a broad distribution of hematopoietic cell types. G/M-CSF can stimulate the production of mature granulocyte, macrophage, or mixed colonies from bone marrow progenitor cells (8, 9) . It also initiates, but does not sustain, proliferation of some multipotential erythroid and megakaryocyte precursors (10) . IL-3 induces colony formation of multiple cell types in cultures of bone marrow or fetal liver cells . It supports the growth and/or differentiation of multipotent precursor cells belonging to both the myeloid and lymphoid lineages as well as more differentiated progenitor cells belonging to the myeloid lineage (2, (11) (12) (13) (14) (15) . IL-3 has also been associated with multiple activities and has been termed burstpromoting activity (16) , mast cell growth factor (17, 18) , P cell stimulating factor (19, 20) , and histamine-producing cell-stimulating factor (21) by various investigators.
The broad spectrum of activities associated with IL-3 suggests that it may play a role in both the self-renewal of multipotent stem cells as well as the growth and differentiation of committed progeny . However, the mechanism by which IL-3 mediates these processes is not understood. In this report, we have studied the Cell cycle compartments in actively cycling or factordeprived cell lines . FDC-P1 (A and B) or FL5 .12 (C and D) cells, either actively cycling (A and C) or 24-h factor-deprived (B and D) were analyzed for DNA and RNA content using the dye acridine orange. x-axis, red flourescence intensity, RNA content per cell; yaxis, green flourescence intensity, DNA content per cell. Box designates Go . groups. In addition, cell number and viability (determined by trypan blue dye exclusion) were monitiored.
Oxidative Phosporylation Enzyme Activity. Oxidative phosphorylation enzyme levels were evaluated as previously described (25) . Briefly, cells were prepared and plated in the same manner as for the ['H]TdR uptake assay except that 105 cells were plated per well. After the indicated time, 0.02 ml of 3(4,5-dimethyl-thiazoyl-2-yl) 2,5-diphenyltetrazolium bromide (MTT; 5 mg/ml in PBS) (Sigma Chemical Co., St. Louis, MO) was added to each well. Plates were then incubated at 37°C for 4 h. The plates were centrifuged, the supernatant removed, and 0.1 ml of acid-isopropanol (0.04 N HCI in isopropanol) was added and mixed. Plates were read on a Flow Multiscan (Flow Laboratories, Inc., McLean, VA) at a test wavelength of 570 Inn and a reference wavelength of 630 nm.
DNA and RNA Content. Simultaneous detection of RNA and DNA levels within single cells was performed using a protocol adapted from Darzynkiewicz et al . (26) . Briefly, 106 washed, viable cells were resuspended in 0.2 ml HBSS containing 1 % FCS . 0.4 ml of 0.08 M HCI, 0.15 M NaCI, and 0.1 % Triton X-100 was added, mixed gently, and incubated for 90 s. Acridine orange solution (12 ,ug/ml) in 0.25 M Na2HPO4, 0.1 M citric acid, 0.2 mM EDTA, and 0.15 M NaCl were then added, and incubated at room temperature, protected from light, for 20 min. 37% ethanol was added and the samples were analyzed using a FACS Analyzer (Becton Dickinson & Co., Mountain View, CA) and Consort 30 computer .
Results
Transition to Go of IL-3-dependent Cell Lines upon Removal of Ligand . FDC-P1 and FL5.12 cells, maintained in WEHI-3 CM, were harvested, washed in HBSS, and cultured at 2 X 105 cells/ml in the presence or absence of WEHI-3 CM. After 24 h, DNA and RNA content of single cells was quantitated by FACS analysis. During exponential growth phase (Fig. 1, A and C) ,^-55, 25, and 20% of these cells are in the GI , S, and G2 + M phases of the cell cycle, respectively. However, when these clones were removed from WEHI-3 CM for >20 h (Fig.  1, B and D) , >95% of all cells exit from the cell cycle and accumulate in Go. Both FDC-P1 and FL5.12 cells grow in serum-free medium in the presence of WEHI-3 CM. These cells also enter Go when deprived of WEHI-3 CM (data not shown) .
We confirmed that such cells were in a resting state by monitoring [3H]TdR uptake, oxidative phosphorylation enzyme levels (MTT assay), total cell volume, and number of viable cells. Fig. 2A (Fig. 2B ) and negligible levels were observed by 24 h of culture. Total cellular volume measurements determined at 24 h also indicate that a substantial decrease in cell size had occurred (Fig. 2C) . Cells in WEHI-3 CM were 15-17 Am in diameter and 7-9 Am in diameter when ligand was removed. 50-70% of the cells were viable 24 h after the removal of WEHI-3 CM (Fig. 2D) , and, at 48 h, >50% of FL5.12 cells remain viable, whereas <10% of FDC-P1 cells are viable . No significant increase in cell number was observed when WEHI-3 CM was removed from the culture medium.
Activation of Growth-arrested Clones with WEHI-3 CM. 24-h factor-deprived cells that have accumulated in the Go phase of the cell cycle enter cycle when cultured in the presence of WEHI-3 CM . For FDC-P1 cells (Fig. 3A) , Go to G, transition occurs between 8 and 12 h, while the G, to S phase transition occurs by 12 h of culture. FL5 .12 cells (Fig. 3A) , move into G, between 4 and 8 h after factor addition, although S phase transition does not occur until^-20 h of culture. Concurrent with the entry of cells into cycle, both [3H]TdR uptake and oxidative phosphorylation enzyme levels increase . FDC-P1 and FL5 .12 cells show a significant and steady increase in [3H]TdR uptake beginning at 12-16 h of culture (Fig. 3B) , while oxidative phosphorylation enzyme levels increase rapidly after WEHI-3 CM addition (Fig. 3 C) . Cell viability in these restimulated cultures is maintained at >90% throughout the culture period and a doubling time of -11-13 h is observed for both cell lines after the initial cell division (Fig. 3D ). Both FDC-P1 and FL5.12 cells maintained in the presence of purified IL-3 behave similarly to cells maintained in WEHI-3 CM, suggesting that IL-3 is the factor responsible for cell growth .
[ 3H]TdR Uptake in IL-3-dependent Clones in Cultures Containing Other CSFs . Several different CSFs were evaluated for their ability to stimulate growth of either activated or resting (Go) FDC-P1 or FL5 .12 cells. FDC-P1 and FL5 .12 cells were maintained long-term in either WEHI-3 CM or purified IL-3 and their pattern of responsiveness to other growth factors was similar (Table I) . We found that only IL-3 or WEHI-3 CM will support growth of FL5.12 cells (Table I) whether these cells were actively cycling or resting (G o) cells. These cells do not uptake [3H]TdR in response to human IL-10, human IL-2, mouse G/M-CSF, or mouse IL-4. In contrast, actively cycling FDC-PI cells (Table I) maintained in the presence of either G/M-CSF or IL-4. To determine whether these cells behave similarly to the cells from which they were derived, the lines were deprived of the respective CSF for 24 h. Unlike FDC-PI cells maintained in either WEHI-3 CM or purified IL-3, FDC-P1 cells adapted for growth in either G/M-CSF or IL-4 did not make a complete transition into Go. The majority of cells accumulated in G, (Fig. 7) . This observation was also confirmed when CSF-deprived cells, restimulated with their respective ligand, quickly progress through G, and rapidly enter S, G2 + M (assessed by [sH]TdR uptake and flow cytometry) by 8-12 h of culture (not shown) .
The finding that FDC-P1 cells maintained in either G/M-CSF or IL-4 were unable to enter Go upon factor removal showed that these cells had altered their growth pattern. We subsequently tested whether such cells might respond differently to other CSF than FDC-P1 cells maintained in IL-3. To investigate this possibility, a panel of CSF were analyzed for their ability to stimulate growth of either cycling or factor-deprived FDC-P1 cells maintained in either G/M-CSF or IL-4. We found that FDC-P1 cells maintained in G/M-CSF will uptake [sH]- TdR in response to WEHI-3 CM, IL-3, IL-4, or G/M-CSF with similar kinetics over a 24-h culture period whether these cells were actively cycling (Fig. 8A ) or 24 h factor-deprived (Fig. 8B) . Therefore, these cells behave differently than cells maintained in IL-3, which lose their ability to enter S phase in response to other CSF when factor-deprived ( Fig. 4; Table 1 ). FDC-P1 cells maintained in IL-4 will uptake [3H]TdR in response to either WEHI-3 CM, IL-3, or IL-4 whether or not they have been factor-deprived for 24 h (Fig. 8, C and D) . However, unlike the cells from which they were derived, these cells lose their ability to respond to G/M-CSF. These results clearly demonstrate that FDC-PI cells maintained in either G/M-CSF or IL-4 are altered in their growth factor responsiveness.
Discussion
The regulation of hematopoietic cellular growth and differentiation involves a complex set of interactions between hematopoietic stem cells and the microenvironment in which they reside . This process enables multipotential hematopoietic stem cells to generate all mature cells of the hematopoietic lineages . Stem cells are defined by their extensive proliferative capacity, their ability to differentiate along multiple lineages, and their ability to undergo self-renewal (27- 29) . Presently, the mechanisms that regulate the growth and differentiation of these pluripotent stem cells are not completely understood.
Two major models have been proposed for the mechanism of stem cell renewal and commitment. The deterministic model of stem cell development suggests that the commitment of pluripotent hematopoietic stem cells to committed progenitors is regulated by the immediate microenvironment of the individual stem cell (30, 31) . Appropriate external stimuli would act directly on stem cells to control commitment resulting in a uniform response to environmental stimuli . In contrast, the stochastic model of stem cell development predicts that multipotential stem cell differentiation is dependent upon different intrinsic probabilities that can be assigned to each of the hematopoietic lineages (32) . These probabilities determine the likelihood of commitment to a specific lineage, with further commitment ofprogenitor cells being governed by progressive restriction in their differentiation potentials (33) . External growth factors would determine which hematopoietic lineage can be derived from multipotential cells by influencing only the probability of such an event occurring within a self-renewing pool of stem cells rather than causing commitment of individual stem cells to a particular lineage (30, 34, 35) either competence or progression factors, depending on the phase of the cell cycle where they are active (34) . Competence factors might be regulators that act on cells in Go and allow them to enter GI . Progression factors would influence cells after interaction with a competence factor and cause these cells to traverse into S, G2, and M . Competence factors may regulate the cells responsiveness to a progression factor by up-or downregulating corresponding growth factor receptors or effecting an intrinsic change among cells recognizing such factors. Thus, it has been suggested that a hierarchy of growth factor responsiveness functionally controls different stages of maturation (36) . This model implies that as a cell matures, it loses its responsiveness to one factor and gains the ability to respond to another.
We have used two IL-3-dependent hematopoietic progenitor clones, FDC-P1 (a myeloid progenitor) and FL5 .12 (a lymphoid progenitor), as a model for the regulation of cell cycle progression in hematopoietic stem cells. The metachromatic fluorochrome acridine orange was used to differentially stain single-versus double-stranded nucleic acids, thus identifying the various phases of the cell cycle. After selective denaturation of dsRNA, cellular DNA and RNA are stained differentially allowing for the discrimination between cells with different RNA content for a given DNA content (26, 37) . It is possible to discriminate between cells in G,, S, and G2 + M phases of the cell cycle based on differences in their green flourescence (DNA content). Further, one can distinguish two qualitatively different compartments of G, according to RNA content, G,A (early G,) and G, B (late G,). The threshold dividing the A and B compartments represents the minimal RNA content of S phase cells, although the distribution of G, phase cells is unimodal with respect to RNA content (37) . Actively cycling cells are fully separated from quiescent (Go) cells based on total cellular RNA content. All quiescent cells have a 2N DNA content and very low RNA content, distinctly lower than G,A cells, such that no overlap in RNA content is observed between Go cells and cells growing exponentially (37) . We found that both FDC-P1 and FL5.12 cells, when deprived of IL-3, could be synchronized in the Go phase of the cell cycle. Accumulation of cells in the Go (resting) compartment was corroborated by direct measurement of RNA and DNA levels within single cells, background levels of both [sH]TdR uptake and oxidative phosphorylation enzyme levels, as well as a significant decrease in cell volume . Furthermore, 24 h after factor deprivation, 50-70% of the cells remain viable . This finding indicates that the majority of cells, rather than a small subpopulation, reach Go before cell death occurs . Upon readdition of IL-3, these factor-deprived lines synchronously enter G, and ultimately progress through the S, G2, and M phases of the cell cycle. Therefore, these results have clearly shown that IL-3 is a competence factor acting on a cell in Go and allowing it to progress into G, . If exposure to IL-3 persists, it functions as a progression factor, allowing cells to traverse from G, into S, G2, and M.
The pivotal role that IL-3 plays in hematopoietic development is shown by the ability of IL-3 to regulate responsiveness to other hematopoietic growth factors. This was demonstrated in FDC-P1 cells that were deprived of IL-3 and accumulated in Go. These cells do not proliferate in response to G/M-CSF or IL-4.
However, when they reenter G, in the presence of IL-3, growth in response to G/M-CSF or IL-4 is observed . These data would indicate that IL-3 can upregulate either the specific receptors for G/M-CSF or IL-4, or a closely related structure necessary for receptor signaling. These results are in contrast to those reported by Walker and coworkers (36) . They suggest that the activity of IL-3 (multi-CSF) could be attributed to its ability to downregulate and thus activate other growth factor receptors. Since their experiments were performed using total bone marrow cells, the assignment of these different CSF receptors to a single class of cells was not possible . The use in our system of a clonal population of cells allows us to investigate ligand-receptor interactions on a clonal level. The generation of a larger panel of hematopoietic progenitor cells, dependent upon IL-3 and/or other CSFs, as well as the development of receptor binding assays, will allow us to determine whether the responsiveness observed in FDC-P 1 cells is a general phenomonen .
We have also found that either G/M-CSF or IL-4 can maintain long-term growth of FDC-PI cells. In the presence of either G/M-CSF or IL-4, a striking change in the regulation of cell cycle progression occurs . Upon removal of factor, these cells accumulate in G, rather then Go. This observation is corroborated by the functional ability of FDC-P1 cells maintained in G/M-CSF or IL-4 to proliferate in response to the same panel of CSFs that they respond to when not factor-deprived . In addition, FDC-PI cells maintained in IL-4 are further distinguished by the loss of their ability to grow in response to G/M-CSF.
The significance of these findings in relationship to normal pluripotent stem cell development in vivo is corroborated by the recent finding (38) that most multipotent stem cells in vivo reside in the resting (G o) state. Upon appropriate stimulation, these quiescent stem cells generate mature cells of all the hematopoietic lineages . In our system, CSF deprivation results in the accumulation of IL-3 dependent clones in Go . However, these resting (Go) cells still remain responsive to IL-3 and upon stimulation, enter G, . At this point, cell growth can be initiated after stimulation with appropriate CSF. IL-3 can provide the necessary signal for Go-+G, transition and when sufficient levels of exogenous IL-3 are present, cells can transit from G,--+M in 11-13 h. This pattern of growth can be maintained in vitro long term. Some IL-3-responsive cells (e.g., FDC-PI) can respond to other CSFs. However, cell growth supported by other CSFs could only be accomplished when cells reside in or beyond late G, or early S phase (8-12 h after IL-3 stimulation (Figs. 5 and 6 ). Maintenance of subsequent cell growth by other CSFs (G/M-CSF or IL-4) was not dependent upon exogenous IL-3 during G, phase and such cells did not transit to Go when depleted of G/M-CSF or IL-4. Loss of IL-3 dependence, failure to exit cell cycle to Go, functional specialization, as well as striking changes in morphology and cell surface phenotype were observed when FDC-P1 cells were grown in G/M-CSF or IL-4.
The manner in which IL-3 regulates growth by supporting self-renewal and rendering some cells competent to long-term growth in response to additional CSFs provides strong clues to the biology of hematopoietic stem cells. Our in vitro model may mimic many features that result in assymetric division of stem cells (self-renewal coordinated with generation of differentiated progeny) and the ability of stem cells to reside for some time in Go. Indeed, normal hematopoiesis may occur through the sequential utilization of different stem cell clones (38, 39) . Recruitment of such clones from a "cryptic" or resting state and their subsequent differentiation program may be dependent upon the stage of cell cycle as well as sequential changes induced by CSF.
Summary
Hematopoietic cell development is regulated by a series of growth factors that are progressively restricted in their biological activity . IL-3 is a multi-lineage growth factor that supports the growth and differentiation of progenitor cells belonging to multiple lineages . However, the mechanism by which IL-3 induces proliferation and differentiation of these cells is not completely understood.
In this report, we have used two IL-3-dependent cell lines, FDC-P1 (a myeloid progenitor) and F15 .12 (a lymphoid progenitor) to investigate IL-3-mediated growth and differentiation . When either FDC-P1 or FL5.12 cells are deprived of IL-3, >90% of all cells accumulate in the Go phase of the cell cycle . Upon readdition of IL-3, the cells will reenter the active phases of the cell cycle . Therefore, IL-3 can act as both a competence (Go->Gl) factor, and a progression (G,--*M) factor for hematopoietic precursor clones.
FDC-P 1 cells can also proliferate in response to granulocyte/macrophage colony-stimulating factor (G/M-CSF) and IL-4 (B cell stimulatory factor 1 [BSF-1 ]). However, resting (Go) FDC-P 1 cells have lost their ability to grow in response to both G/M-CSF and IL-4, even though both factors can induce a Go-->Gl transition . Therefore, G/M-CSF or IL-4 behave as progression factors among certain IL-3-responsive clones, and in those cases only in defined points in the cell cycle.
Both IL-4 and G/M-CSF can maintain long-term growth of FDC-P1 cells. Upon removal of factor for 24 h, these clones accumulate in the G, phase of the cell cycle and do not appear to enter Go even after 36 h of factor deprivation . Therefore, cells maintained in G/M-CSF or IL-4 have altered growth requirements compared with the IL-3-dependent lines from which they were derived . The ability of various hematopoietic growth factors to regulate cell cycle progression in IL-3-dependent cell lines is dependent not only upon the lineage from which these cells were derived, but also the phase of the cell cycle in which those cells reside . The consequences of these interactions dictate the manner by which various clones will respond to CSFs and whether the cells will grow and/or differentiate .
